These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 762652)

  • 1. Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model.
    Fischer JF; Cho AK
    J Pharmacol Exp Ther; 1979 Feb; 208(2):203-9. PubMed ID: 762652
    [No Abstract]   [Full Text] [Related]  

  • 2. Properties of dopamine efflux from rat striatal tissue caused by amphetamine and p-hydroxyamphetamine.
    Fischer JF; Cho AK
    Proc West Pharmacol Soc; 1976; 19():179-82. PubMed ID: 995984
    [No Abstract]   [Full Text] [Related]  

  • 3. The contribution of the metabolite p-hydroxyamphetamine to the central actions of p-methoxyamphetamine.
    Kaminskas LM; Irvine RJ; Callaghan PD; White JM; Kirkbride P
    Psychopharmacology (Berl); 2002 Mar; 160(2):155-60. PubMed ID: 11875633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurochemical effects of amphetamine metabolites on central dopaminergic and serotonergic systems.
    Matsuda LA; Hanson GR; Gibb JW
    J Pharmacol Exp Ther; 1989 Dec; 251(3):901-8. PubMed ID: 2600821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of 4-hydroxyamphetamine by rat striatal homogenates.
    Cho AK; Schaffer JC; Fischer JF
    Biochem Pharmacol; 1975 Aug; 24(16):1540-2. PubMed ID: 1191311
    [No Abstract]   [Full Text] [Related]  

  • 6. The accumulation of p-hydroxyamphetamine by brain homogenates and its role in the release of catecholamines.
    Cho AK; Fischer JF; Schaeffer JC
    Biochem Pharmacol; 1977 Aug; 26(15):1367-72. PubMed ID: 901551
    [No Abstract]   [Full Text] [Related]  

  • 7. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
    Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of phencyclidine, amphetamine and related compounds on dopamine release from and uptake into striatal synaptosomes.
    Bowyer JF; Spuhler KP; Weiner N
    J Pharmacol Exp Ther; 1984 Jun; 229(3):671-80. PubMed ID: 6726652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the mechanism of stimulation of dopamine synthesis by amphetamine in striatal slices.
    Uretsky NJ; Snodgrass SR
    J Pharmacol Exp Ther; 1977 Sep; 202(3):565-80. PubMed ID: 197227
    [No Abstract]   [Full Text] [Related]  

  • 10. Selective storage of p-hydroxy-d-amphetamine in the dopaminergic nerve terminals.
    Jori A; Caccia S; Guiso A; Ballabio M; Garattini S
    Biochem Pharmacol; 1979 Apr; 28(7):1205-7. PubMed ID: 444278
    [No Abstract]   [Full Text] [Related]  

  • 11. The accumulation of dopamine into striatal synaptosomes, and its inhibition: comparison of crude, partially purified and purified synaptosomal preparations.
    Tuomisto J; Tuomisto L
    Med Biol; 1979 Aug; 57(4):238-45. PubMed ID: 513880
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of N-acetylcysteine on amphetamine-mediated dopamine release in rat brain striatal slices by ion-pair reversed-phase high performance liquid chromatography.
    Gere-Pászti E; Jakus J
    Biomed Chromatogr; 2009 Jun; 23(6):658-64. PubMed ID: 19277967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microdialysis measurement of striatal dopamine levels in freely moving rats after cocaine or amphetamine treatment.
    Ivens IA; Janak PH; Martinez JL
    Proc West Pharmacol Soc; 1992; 35():165-9. PubMed ID: 1502217
    [No Abstract]   [Full Text] [Related]  

  • 14. Further characterization of structural requirements for agonists at the striatal dopamine D2 receptor and a comparison with those at the striatal dopamine D1 receptor. Studies with a series of monohydroxyaminotetralins on acetylcholine release from rat striatum.
    Seiler MP; Markstein R
    Mol Pharmacol; 1984 Nov; 26(3):452-7. PubMed ID: 6238231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of estrogen agonists on amphetamine-stimulated striatal dopamine release.
    Xiao L; Becker JB
    Synapse; 1998 Aug; 29(4):379-91. PubMed ID: 9661256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steric requirements for catecholamine uptake by rat brain synaptosomes: studies with rigid analogs of amphetamine.
    Horn AS; Snyder SH
    J Pharmacol Exp Ther; 1972 Mar; 180(3):523-30. PubMed ID: 5012779
    [No Abstract]   [Full Text] [Related]  

  • 17. Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum.
    Biggs CS; Starr MS
    Synapse; 1999 Oct; 34(1):36-46. PubMed ID: 10459170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between asymmetries in striatal dopamine release and the direction of amphetamine-induced rotation during the first week following a unilateral 6-OHDA lesion of the substantia nigra.
    Robinson TE; Noordhoorn M; Chan EM; Mocsary Z; Camp DM; Whishaw IQ
    Synapse; 1994 May; 17(1):16-25. PubMed ID: 8042143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of rapid superfusion to differentiate the release of dopamine from striatal tissue induced by sympathomimetic amines from release induced by potassium.
    Caviness JN; Wightman RM
    J Pharmacol Exp Ther; 1982 Oct; 223(1):90-6. PubMed ID: 7120132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early changes in neuropeptide mRNA expression in the striatum following reserpine treatment.
    Harrison MB; Kumar S; Hubbard CA; Trugman JM
    Exp Neurol; 2001 Feb; 167(2):321-8. PubMed ID: 11161620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.